555 related articles for article (PubMed ID: 15148531)
1. Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension.
Budev MM; Minai OA; Arroliga AC
Drugs Today (Barc); 2004 Mar; 40(3):225-34. PubMed ID: 15148531
[TBL] [Abstract][Full Text] [Related]
2. The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.
Gessler T; Seeger W; Schmehl T
Ther Adv Respir Dis; 2011 Jun; 5(3):195-206. PubMed ID: 21300738
[TBL] [Abstract][Full Text] [Related]
3. The role of treprostinil in the management of pulmonary hypertension.
Skoro-Sajer N; Lang I
Am J Cardiovasc Drugs; 2008; 8(4):213-7. PubMed ID: 18690755
[TBL] [Abstract][Full Text] [Related]
4. Treprostinil for pulmonary hypertension.
Skoro-Sajer N; Lang I; Naeije R
Vasc Health Risk Manag; 2008; 4(3):507-13. PubMed ID: 18827901
[TBL] [Abstract][Full Text] [Related]
5. Treprostinil therapy for pulmonary artery hypertension.
Horn EM; Barst RJ
Expert Opin Investig Drugs; 2002 Nov; 11(11):1615-22. PubMed ID: 12437507
[TBL] [Abstract][Full Text] [Related]
6. Experiences with treprostinil in the treatment of pulmonary arterial hypertension.
Stream AR; Bull TM
Ther Adv Respir Dis; 2012 Oct; 6(5):269-76. PubMed ID: 22868690
[TBL] [Abstract][Full Text] [Related]
7. Treprostinil for the treatment of pulmonary arterial hypertension.
Torres F; Rubin LJ
Expert Rev Cardiovasc Ther; 2013 Jan; 11(1):13-25. PubMed ID: 23259441
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of prostacyclins in pulmonary arterial hypertension.
Roman A; Barberà JA; Escribano P; Sala ML; Febrer L; Oyagüez I; Sabater E; Casado MA
Appl Health Econ Health Policy; 2012 May; 10(3):175-88. PubMed ID: 22452448
[TBL] [Abstract][Full Text] [Related]
9. Prostanoids for pulmonary arterial hypertension.
Galiè N; Manes A; Branzi A
Am J Respir Med; 2003; 2(2):123-37. PubMed ID: 14720012
[TBL] [Abstract][Full Text] [Related]
10. Inhaled treprostinil: a therapeutic review.
Channick RN; Voswinckel R; Rubin LJ
Drug Des Devel Ther; 2012; 6():19-28. PubMed ID: 22291467
[TBL] [Abstract][Full Text] [Related]
11. One-year experience with intravenous treprostinil for pulmonary arterial hypertension.
Benza RL; Tapson VF; Gomberg-Maitland M; Poms A; Barst RJ; McLaughlin VV
J Heart Lung Transplant; 2013 Sep; 32(9):889-96. PubMed ID: 23953817
[TBL] [Abstract][Full Text] [Related]
12. Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan.
Benza RL; Rayburn BK; Tallaj JA; Pamboukian SV; Bourge RC
Chest; 2008 Jul; 134(1):139-45. PubMed ID: 18403673
[TBL] [Abstract][Full Text] [Related]
13. [Role of prostacyclin and its derivatives in the treatment of pulmonary arterial hypertension].
Osvaldo Cáneva J; Ossés JM
Medicina (B Aires); 2003; 63(3):233-6. PubMed ID: 12876911
[TBL] [Abstract][Full Text] [Related]
14. Treprostinil for pulmonary hypertension.
Vachiéry JL; Naeije R
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):183-91. PubMed ID: 15151467
[TBL] [Abstract][Full Text] [Related]
15. Prostanoid therapy for pulmonary arterial hypertension.
Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of prostacyclin and its analogs in the management of pulmonary arterial hypertension.
Dandel M; Hetzer R
Curr Vasc Pharmacol; 2003 Jun; 1(2):171-81. PubMed ID: 15320842
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment, tolerability, and survival with sub-cutaneous treprostinil for severe pulmonary hypertension.
Sadushi-Koliçi R; Skoro-Sajer N; Zimmer D; Bonderman D; Schemper M; Klepetko W; Glatz J; Jakowitsch J; Lang IM
J Heart Lung Transplant; 2012 Jul; 31(7):735-43. PubMed ID: 22480725
[TBL] [Abstract][Full Text] [Related]
18. Prostacyclin for pulmonary hypertension in adults.
Paramothayan NS; Lasserson TJ; Wells AU; Walters EH
Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002994. PubMed ID: 15846646
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension.
Benza RL; Seeger W; McLaughlin VV; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubin LJ
J Heart Lung Transplant; 2011 Dec; 30(12):1327-33. PubMed ID: 22055098
[TBL] [Abstract][Full Text] [Related]
20. Prostacyclin for pulmonary hypertension.
Paramothayan NS; Lasserson TJ; Wells AU; Walters EH
Cochrane Database Syst Rev; 2003; (2):CD002994. PubMed ID: 12804447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]